US FDA approves Novartis' gene therapy for rare muscle disorder

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community

The Muscular Dystrophy Association (MDA) today called the U.S. Food and Drug Administration’s approval of Itvisma (onasemnogene abeparvovec-brve), developed by Novartis, a major step forward for ...
KTAR

Phoenix doctor leads effort on newly approved alternative to open heart surgery

A Phoenix doctor helped develop live-saving treatment for a dangerous heart condition called mitral annular calcification, or ...
Stars Insider on MSN

Supplements that help your immune system

How do we ensure our immune system is in good shape? Well, there are a few things we can do to boost it, including eating the ...

Whitecaps’ nine-man wonder, Eze rubs salt into Spurs wounds, Ronaldo’s acrobatic screamer

Vancouver Whitecaps get out of jail with nine men, Eze makes Spurs rue failed move, Ronaldo back at it with bicycle kick ...

Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell ...